9th International Conference on Autoimmunity: Mechanisms and Novel Treatments

Program

Saturday, October 12

     

7:00 PM

 

Conference Registration

     

8:00 PM

 

Welcome Reception / Dinner

     

Sunday, October 13

     

7:30 AM

 

Breakfast

     

8:25 AM

 

Welcome / Opening Remarks

     

SESSION I

   

8:30 AM

1

Understanding Multiple Sclerosis progression using translational and reverse-translational approaches

Olga Rojas, Ann-Katrin Proebstel, Valeria Ramaglia, Angela Wang, Amit Bar-Or, Alex Prat, Sergio Baranzini, and Jennifer Gommerman

9:00 AM

2

The role of diet in the development of colitis

Sergio Lira

9:30 AM

3

Treatment of experimental autoimmune encephalomyelitis with nucleoside-modified mRNA coding for disease-related autoantigens

Christina Krienke, Laura Kolb, Elif Diken, Michael Streuber, and Ugur Sahin

9:45 AM

4

Susac syndrome as a CD8+ T-cell-mediated endotheliopathy of the central nervous system

Roland Liblau

10:15 AM

5

Maintenance of regulatory T cell identity at sites of inflammation through epigenetic imprinting

Thomas Korn

     

10:45 AM

 

Coffee Break

     

SESSION II

   

11:15 AM

6

Generation of memory T helper cells and regulation of airway inflammation

Toshinori Nakayama

11:45 PM

7

Infection-induced changes in the immune system and their impact on disease susceptibility

Michelle Schorer, Tamas Dolowschiak, Nikolas Rakebandt, and Nicole Joller

12:15 PM

8

Foxp3-specific deletion of CREB generates ST-2 positive regulatory T-cells with enhanced IL-10 production and suppressive capacity

Klaus Tenbrock

12:30 PM

9

Exon 2 of the Foxp3 gene regulates IgE-mediated cutaneous autoimmunity after ultraviolet-B light challenge

Phillip Domeier, Sarah E. Chang, Sabine Spath, Paul J. Utz, Baohua Zhou, and Steve Ziegler

1:00 PM

10

TBD

Yasmine Belkaid

     

1:30 PM

 

Lunch and Informal Discussions

     

7:30 PM

 

Dinner and Informal Discussions

Buses depart from the hotel lobby at 7:30 PM

     
       

Monday, October 14

     

7:30 AM

 

Breakfast

     

SESSION III

   

8:30 AM

11

Cytokine regulation of brain macrophages

Melanie Greter

9:00 AM

12

Probing the IL10 axis in Gut and Brain Macrophage

Biana Bernshtein, Anat  Shemer, Zhana Haimon, and Steffen Jung

9:30 AM

13

Nucleic acid recognition through cGAS/STING aggravates ANCA-associated vasculitis in the lung

Susanne Viehmann, Nina Kessler, Christine Schmidt, Daniela Klaus, Hella Luksch, Simon Otten, Peter Boor, Calvin Krollmann, Lino Teichmann, Angela Rösen-Wolff, Peter Heeringa, Natalio Garbi, and Christian Kurts

9:45 AM

14

TLR signaling, monocyte differentiation, and macrophage activation syndrome

Jessica Hamerman, Holly Akilesh, Matthew Buechler, Jeffrey Duggan, Bharati Matta, Scott Presnell, Keith Elkon, Adam Lacy-Hulbert, Betsy Barnes, and Marion Pepper

10:15 AM

15

Macrophage and dendritic cell biology

Florent Ginhoux

     

10:45 AM

 

Coffee Break

     

SESSION IV

   

11:15 AM

16

Human T cells subsets in immunity and autoimmunity

Federica Sallusto

11:45 AM

17

Manipulating the IL-2 pathway for control of autoimmunity

Daniel J Campbell, Liliane Khoryati, Minh Pham, Erika Hayes, and Marc Gavin

12:15 PM

18

The protective role of IL-12 in psoriasis

Pascale Zwicky, Myrto Andreadou, Sarah Mundt, and Burkhard Becher

12:30 PM

19

X-chromosome inactivation maintenance is perturbed in lymphocytes from human lupus patients and a mouse model of lupus

Montserrat Anguera, Bam Paneru, and Camille Syrett

1:00 PM

20

Identification of natural regulatory plasma cells

Simon Fillatreau

     

1:30 PM

 

Lunch and Informal Discussions

     

7:30 PM

 

Dinner and Informal Discussions

Buses depart from the hotel lobby at 7:30 PM

     

Tuesday, October 15

     

7:30 AM

 

Breakfast

     

SESSION V

   

8:30 AM

21

Connecting autoimmunity and cancer immunity in mice and humans

Jeffrey Bluestone

9:00 AM

22

Control of Autoimmunity by CTLA-4-dependent Treg function

Lucy Walker

9:30 AM

23

Circulation of human cutaneous resident memory CD4 T cells

Maria Klicznik, Peter Morawski, Barbara Höllbacher, Suraj Varkhande, Samantha Motley, Thomas Duhen, Michael Betts, Daniel Campbell, and Iris Gratz

10:00 AM

24

Spontaneous protein crystallization as a driver of immunity

Emma Persson, Kenneth Verstraete, Ines Heyndrickx, Helena Aegerter, Elien Gevaert, Jean-Michel Percier, Kim Deswarte, Ann Dansercoer, Koen Verschueren, Delphine Gras, Pascal Chanez, Claus Bachert, Hanne Van Gorp, Hans De Haard, Christophe Blanchetot, Michael Saunders, Hamida Hammad, Savvas Savvides, and Bart Lambrecht

     

10:30 AM

 

Coffee Break and Poster Session

     

SESSION VI

 

Cellular Immunology

12:00 PM

25

Engineering antigen-expressing regulatory T cells to modulate adverse immune responses

David Scott

12:30 PM

26

IL-17 controls CNS autoimmunity through the intestinal microbiome

Ari Waisman

1:00 PM

27

Thymic education: Treg formation trumps negative selection

Burkhard Becher

     

1:30 PM

 

Lunch and Informal Discussions

     

3:30 PM

 

City Tour

Buses depart from hotel lobby at 3:30 PM

     

7:30 PM

 

Dinner and Informal Discussions

Please note that buses do not pick-up at the hotel prior to dinner.

Dinner proceeds right after the tour

     

Wednesday, October 16

     

7:30 AM

 

Breakfast

     

SESSION VII

   

8:30 AM

28

Targeting Regulatory T cells for Therapeutic Gain: Means and Mechanisms

Sergio Quezada

9:00 AM

29

Metabolic programs controlling immune cell function

Tim Sparwasser

9:30 AM

30

Control of human B cell responses by follicular regulatory cells

Carola Vinuessa

10:00 AM

31

Alpha V integrins and non-canonical autophagy regulate TLR-driven autoimmunity

Adam Lacy-Hulbert, Fiona Raso, Sara Sagadiev, Alina Lorant, Sara Sagadiev, Emily Gilbertson, and Mridu Acharya

10:15 AM

32

Patients with PIK3CD gain-of-function mutations reveal a critical role for PI3K in controlling multiple stages of B cell tolerance

Elissa Deenick, Anthony Lau, Stuart Tangye, and Danielle Avery

     

10:30 AM

 

Coffee Break

     

SESSION VIII

 

11:00 AM

33

Regulation of Th17 by IL-17: implications for autoimmunity

Rachel Caspi

11:30 AM

34

Molecular control of astrocyte pathogenic activities in MS 

Francisco Quintana

12:00 PM

35

Granzyme B: A key contributor to the progression of pemphigoid diseases, a subtype of autoimmune Blistering disorders

David Granville, Sho Hiroyasu, Matthew Zeglinski, Ralph Ludwig, Anika Kasprick, Chiharu Tateishi, Wataru Nishie, Daisuke Tsuruta, and Hiroshi Shimizu

12:15 PM

36

A high-salt diet compromises the neutrophil response against bacterial infections through metabolic and hormonal perturbations

Christian Kurts

12:45 PM

37

Modelling T-cell autoimmunity of the CNS grey and white matter

Francesca Odoardi

     

1:15 PM

 

Closing Remark

     

1:30 PM

 

Lunch / Informal Discussions

     

8:00 PM

 

Farewell Dinner

     

Thursday, October 17

     

7:30 AM

 

Breakfast

     
   

Departure


POSTERS

38

Therapeutic blockade of CD40-CD154 interactions suppresses proteinuria in the NZB/W F1 mouse model of lupus nephritis

Barbara Nuesslein-Hildesheim, Frederique Lafossas, Grazyna Wieczorek, Melanie Ceci, Swann Gaulis, Giovanni Palla, Katriona McMichael, Enrico Ferrero, and James Rush

39

Nucleic acid recognition through specific receptors aggravates ANCA-associated vasculitis

Christian Kurts

40

Successful anti-fibrotic treatment of interstitial pneumonia with autoimmune diseases in the basis of molecular pathogenesis

Masahito Ebina

41

The protective role of IL-12 in autoimmune neuroinflammation

Myrto Andreadou, Pascale Zwicky, Pascale Eede, Frank Heppner, Sarah Mundt, and Burkhard Becher

42

Novel aspects of IRAK1 kinase function in autoimmunity

Thomas Hoyler, Giulia Ruzzante, Geraldine Zipfel, Anja Scheidegger, Sophie Sarret, Nadja Caesar, Janet Dawson King, Thomas Boulay, Grazyna Wieczorek, Amanda Littlewood-Evans, Pius Loetscher, Stuart Hawtin, and Tobias Junt

43

Fab-arm exchange dependent autoimmunity in MuSK myasthenia gravis

Dana Vergoossen, Yvonne Fillié-Grijpma, Jaap Plomp, Cor Breukel, Elena Dominguez Vega, Christoph Gstöttner, Paul Parren, Silvère van der Maarel, Jan Verschuuren, and Maartje Huijbers

44

The expanding field of IgG4-mediated autoimmune diseases

Maartje Huijbers, Dana Vergoossen, Yvonne Fillié-Grijpma, Jaap Plomp, Silvère van der Maarel, and Jan Verschuuren

45

Linking the Xist ribonucleoprorein complex to female-biased autoimmune diseases

Diana Dou, Yang Zhao, Yanyan Qi, Jin Xu, Anton Wutz, PJ Utz, and Howard Chang

46

Polymorphonuclear neutrophils and regulatory T lymphocytes (Treg) cooperate to sustain Treg activity but this interaction is altered in rheumatoid arthritis patients

Maxime Batignes, François Santinon, Marie-Christophe Boissier, Natacha Bessis, and Patrice Decker

47

Antigen-encoding bone marrow deletes mature antigen-specific B cells in recipients and inhibits antigen-specific antibody production 

Raymond Steptoe, Jeremy Brooks, and James Wells

48

Progression of Cerebellar atrophy in anti-NMDA encephalitis and associated clinical parameters

Sang Kun Lee, Woo-Jin Lee, and Soon-Tae Lee

49

Development of a novel, blocking anti-CD40 monoclonal antibody for kidney transplantation and autoimmune disease

James Rush

50

Mechanism-guided novel therapies for treating inflammatory diseases

Sylviane Muller

51

Autoantibodies against BP180 in bullous pemphigoid, Alzheimer’s disease and multiple sclerosis

Jussi Tuusa, Outi Lindgren, Hanna-Mari Tertsunen, Wataru Nishie, Nina Kokkonen, Laura Huilaja, Kentaro Izumi, Sanna-Kaisa Herukka, Jouko Miettunen, Hiroshi Shimizu, Anne Remes, and Kaisa Tasanen

52

Altered early life exposures due to immigration patterns and autoinflammatory diseases: Evaluation of the T cell immune response to commensal bacteria

Ikbel Naouar, Gary Chao, julia Copeland, David S Guttman, Jayne Danska, Philippe Poussier, Ken Croitoru, Ahmed El-Sohemy, Geoffrey Nguyen, Anne Griffiths, Andrew Paterson, John Parkinson, Kathi Wilson, and Jennifer Gommerman

53

overexpression of NF-κB-inducing kinase (NIK) affects suppressive capacity of regulatory T cells

Anna Ebering

54

The role of IL-34-mediated CSF-1R signalling in tumour development

Dilay Cansever and Melanie Greter

55

CSF1-R signaling regulates CNS macrophage development and function

Wiebke Mildenberger, Sebastian G Utz, Burkhard Becher, and Melanie Greter

56

Biological therapy inhibits autoimmunity in psoriasis

Loredana Frasca, Raffaella Palazzo, Rebecca Favaro, Antonio Costanzo, and Roberto Lande

57

The role of IL-1R signaling in monocyte-derived phagocyte-mediated neuroinflammation

Donatella De Feo, Ana Amorim, Friebel Ekaterina, Ari Waisman, Melanie Greter, and Burkhard Becher